0.02
-12.50%
Close of 6 Nov 2026, in SGD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
Price performance
Chart by TradingView, with its own licensed prices
No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.
View Embracing Future Holdings on TradingView ↗- Market value
- SGD 36.4m
- Last close × shares
- Volume
- 317.6k
- Shares, 6 Nov 2026
About Embracing Future Holdings
Its shares trade on SGX under the ticker 8YY.SI. It has been listed since 19 December 2018. In the fiscal year to 31 December 2025, it reported revenue of SGD 5.3m and a net loss of SGD 4.0m. At that date it held total assets of SGD 5.1m and shareholders' equity of SGD 1.5m.
Biolidics Ltd. is a medical technology company, which engages in the development of diagnostic solutions for healthcare and clinical purposes. The firm's principal activities are technology development, technology transfer, marketing, selling and distribution of biomedical technology, life and medicine science related products and services; provision of laboratory services; and investment holding. The company has three segments: cancer diagnostics, infectious diseases and laboratory services. Cancer diagnostics segment develops and commercializes the ClearCell FX1 System, a fully automated CE-IVD medical device, which separate and enrich cancer cells from blood, allows users of the system to perform liquid biopsies. Infectious diseases segment develops, markets and/or distributes certified test kits with various diagnostic partners. Laboratory services segment offers a range of tests. The laboratory has a regulatory approval from Singapore’s Ministry of Health for molecular microbiology testing and PCR testing services for COVID-19 in Singapore.
Figures and description from our data supplier, not checked against the company's own report.
Latest on Embracing Future Holdings
Our reporting
- Interview: Wissam Khoury, Finastra – Embracing the future of open treasury and capital markets solutions
- Joshua Denne: Embracing AI for a Future of Infinite Possibilities
- Embracing Change: NICE Actimize on Generative AI, Cloud and the Future of Financial Crime
- Embracing the Future: The Role of Generative AI in Enhancing Compliance in Banking
- The future of ATMs: Embracing new management models & agile tech architectures
- THE FUTURE OF TECH: Embracing the right technology with the right people for business success
Next results
Due on 26 Feb 2027.
Other Health Care listings
Scenario calculator
Try your own numbers. This is arithmetic, not a forecast.
Gain or loss
Return
Leaves out fees, taxes and financing.
Frequently asked questions
What is Embracing Future Holdings's ticker?
Embracing Future Holdings trades as 8YY.SI on SGX, under ISIN SGXE89830751.
What was Embracing Future Holdings's last closing price?
0.02 on 6 Nov 2026. The figure is in SGD and is never converted.
When does Embracing Future Holdings next report results?
Results are expected on 26 Feb 2027, according to our data supplier.
Sources and methodology
- Chart
- TradingView
- Close and company data
- Our data supplier
- News
- Our reporting
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.